Together, we can navigate this path to wellness
The COA should test for Dihexa specifically (correct mass, correct CAS), not a generic "peptide" assay
(PubMed) Yang L, Calingasan NY, Wille EJ, et al
In practice, most interest clusters around these real world goals: Skin quality and visible aging Wound healing support (when appropriate), which aligns with the principles of regenerative therapy Hair and scalp health conversations (still evolving, mixed quality evidence) Joint, tendon, connective tissue support as part of a bigger plan Recovery support, again in context And for some patients, the longevity benefit is simply this: better tissue repair capacity and less chronic inflammatory signaling can improve quality of life
Risks: Slower and less effective compared to injections